Predictive value of clinical judgment of tumour progression in phase II trials.

<h4>Background</h4>The diagnosis of tumour progression or progressive disease (PD) is a key element for designing and interpreting contemporary phase II trials. In some cases, PD is stated by the physician and is not formally confirmed by imaging.<h4>Purpose</h4>In this study...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Nuria Kotecki, Nicolas Penel, Antoine Adenis, Charles Ferte, Stéphanie Clisant
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2012
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/3863f9b65184415893c32d5361af0b0c
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!